Glass yttrium-90 microspheres for patients with colorectal liver metastases.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 1438931.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Total calculated uniform liver doses of up to 150 Gy were achieved using glass yttrium-90 microspheres administered via the hepatic artery and targeted to tumour using angiotensin II in seven patients with colorectal liver metastases. No toxicity was observed. Hepatic metastatic progression was delayed in six patients. Median survival was 11 months (range 5-25 + months).
Medical subject headings
- Colorectal Neoplasms
- Liver Neoplasms
- Yttrium Radioisotopes